BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 22945592)

  • 1. The genetics of hyperuricaemia and gout.
    Reginato AM; Mount DB; Yang I; Choi HK
    Nat Rev Rheumatol; 2012 Oct; 8(10):610-21. PubMed ID: 22945592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
    Torres RJ; Puig JG
    Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of hyperuricemia and gout: implications for the present and future.
    George RL; Keenan RT
    Curr Rheumatol Rep; 2013 Feb; 15(2):309. PubMed ID: 23307580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetic basis of hyperuricaemia and gout.
    Merriman TR; Dalbeth N
    Joint Bone Spine; 2011 Jan; 78(1):35-40. PubMed ID: 20472486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of four genetic loci with uric acid levels and reduced renal function: the J-SHIPP Suita study.
    Tabara Y; Kohara K; Kawamoto R; Hiura Y; Nishimura K; Morisaki T; Kokubo Y; Okamura T; Tomoike H; Iwai N; Miki T
    Am J Nephrol; 2010; 32(3):279-286. PubMed ID: 20714133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex analysis of urate transporters SLC2A9, SLC22A12 and functional characterization of non-synonymous allelic variants of GLUT9 in the Czech population: no evidence of effect on hyperuricemia and gout.
    Hurba O; Mancikova A; Krylov V; Pavlikova M; Pavelka K; Stibůrková B
    PLoS One; 2014; 9(9):e107902. PubMed ID: 25268603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies.
    Anzai N; Jutabha P; Amonpatumrat-Takahashi S; Sakurai H
    Clin Exp Nephrol; 2012 Feb; 16(1):89-95. PubMed ID: 22038265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects.
    Takei R; Cadzow M; Markie D; Bixley M; Phipps-Green A; Major TJ; Li C; Choi HK; Li Z; Hu H; ; Guo H; He M; Shi Y; Stamp LK; Dalbeth N; Merriman TR; Wei WH
    J Hum Genet; 2021 Feb; 66(2):161-169. PubMed ID: 32778763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between genetic polymorphisms in ABCG2 and SLC2A9 and urate: an updated systematic review and meta-analysis.
    Lukkunaprasit T; Rattanasiri S; Turongkaravee S; Suvannang N; Ingsathit A; Attia J; Thakkinstian A
    BMC Med Genet; 2020 Oct; 21(1):210. PubMed ID: 33087043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rs2231142 variant of the ABCG2 gene is associated with uric acid levels and gout among Japanese people.
    Yamagishi K; Tanigawa T; Kitamura A; Köttgen A; Folsom AR; Iso H;
    Rheumatology (Oxford); 2010 Aug; 49(8):1461-5. PubMed ID: 20421215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCG2 rs2231142 variant in hyperuricemia is modified by SLC2A9 and SLC22A12 polymorphisms and cardiovascular risk factors in an elderly community-dwelling population.
    Liu J; Yang W; Li Y; Wei Z; Dan X
    BMC Med Genet; 2020 Mar; 21(1):54. PubMed ID: 32183743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on the genetic architecture of hyperuricemia and gout.
    Merriman TR
    Arthritis Res Ther; 2015 Apr; 17(1):98. PubMed ID: 25889045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ROLE OF SLC2A9 AND ABCG2 GENE POLYMORPHISMS IN ORIGIN OF HYPERURICEMIA AND GOUT].
    Fadieieva A; Prystupa L; Pogorelova O; Kirichenko N; Dudchenko I
    Georgian Med News; 2016 Mar; (252):79-83. PubMed ID: 27119840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of gout.
    Choi HK; Zhu Y; Mount DB
    Curr Opin Rheumatol; 2010 Mar; 22(2):144-51. PubMed ID: 20110790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of
    Duong NT; Ngoc NT; Thang NTM; Phuong BTH; Nga NT; Tinh ND; Quynh DH; Ton ND; Hai NV
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30621105
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.
    Toyoda Y; Pavelcová K; Bohatá J; Ješina P; Kubota Y; Suzuki H; Takada T; Stiburkova B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive composite ABCG2, SLC2A9 and SLC22A12 scores of high-risk alleles with alcohol use modulate gout risk.
    Tu HP; Chung CM; Min-Shan Ko A; Lee SS; Lai HM; Lee CH; Huang CM; Liu CS; Ko YC
    J Hum Genet; 2016 Sep; 61(9):803-10. PubMed ID: 27225847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential gene expression of ABCG2, SLC22A12, IL-1β, and ALPK1 in peripheral blood leukocytes of primary gout patients with hyperuricemia and their comorbidities: a case-control study.
    Natsuko PD; Laura SC; Denise CC; Lucio VR; Carlos AS; Fausto SM; Ambar LM
    Eur J Med Res; 2022 May; 27(1):62. PubMed ID: 35505381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Influences on Hyperuricemia and Gout.
    Merriman T
    Rheum Dis Clin North Am; 2017 Aug; 43(3):389-399. PubMed ID: 28711141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCG2 as a therapeutic target candidate for gout.
    Fujita K; Ichida K
    Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.